Etienne C, Vilcu A, Finet F, Chawki S, Blanchon T, Steichen O
BMC Infect Dis. 2024; 24(1):1184.
PMID: 39434000
PMC: 11492539.
DOI: 10.1186/s12879-024-10039-2.
Gordon K, Blauvelt A, Bachelez H, Coates L, Van den Bosch F, Kaplan B
Dermatol Ther (Heidelb). 2024; 14(9):2523-2538.
PMID: 39153059
PMC: 11393270.
DOI: 10.1007/s13555-024-01238-5.
Dilokthornsakul P, Sawangjit R, Noppakun N, Rajatanavin N, Pattamadilok B, Chularojanamontri L
PLoS One. 2024; 19(8):e0307050.
PMID: 39121033
PMC: 11315331.
DOI: 10.1371/journal.pone.0307050.
Song Y, Chen W, Yin Y, Li J, Wang M, Liu Y
Curr Pharm Des. 2024; 30(35):2753-2764.
PMID: 39092731
DOI: 10.2174/0113816128305190240718112945.
Ma J, Cai J, Chen H, Feng Z, Yang G
J Atheroscler Thromb. 2024; 31(12):1733-1747.
PMID: 38866553
PMC: 11620835.
DOI: 10.5551/jat.64767.
A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar) in the management of psoriasis with scalp involvement.
Staubach P, Korber A, Trueb R, Mann C, von Kiedrowski R
Drugs Context. 2024; 13.
PMID: 38770372
PMC: 11104291.
DOI: 10.7573/dic.2024-1-6.
, and : Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis.
Membrive-Jimenez C, Vieira-Maroun S, Marquez-Pete N, Cura Y, Perez-Ramirez C, Tercedor-Sanchez J
Biomedicines. 2023; 11(9).
PMID: 37761008
PMC: 10526923.
DOI: 10.3390/biomedicines11092567.
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus.
Burlando M, Campione E, Cuccia A, Malara G, Naldi L, Prignano F
Dermatol Reports. 2023; 15(2):9613.
PMID: 37426359
PMC: 10327668.
DOI: 10.4081/dr.2023.9613.
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey.
Thai S, Barlow S, Lucas J, Piercy J, Zhong Y, Zhuo J
Dermatol Ther (Heidelb). 2023; 13(6):1289-1303.
PMID: 37253874
PMC: 10264339.
DOI: 10.1007/s13555-023-00927-x.
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis.
Membrive-Jimenez C, Perez-Ramirez C, Arias-Santiago S, Richetta A, Ottini L, Pineda-Lancheros L
Int J Mol Sci. 2023; 24(10).
PMID: 37240048
PMC: 10218224.
DOI: 10.3390/ijms24108703.
Psoriatic Resolved Skin Epidermal Keratinocytes Retain Disease-Residual Transcriptomic and Epigenomic Profiles.
Ghaffarinia A, Ayaydin F, Poliska S, Manczinger M, Bolla B, Flink L
Int J Mol Sci. 2023; 24(5).
PMID: 36901987
PMC: 10002496.
DOI: 10.3390/ijms24054556.
Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis.
Balato A, Scala E, Eyerich K, Brembilla N, Chiricozzi A, Sabat R
Dermatol Pract Concept. 2023; 13(1).
PMID: 36892377
PMC: 9946081.
DOI: 10.5826/dpc.1301a16.
Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China.
Yang J, Hu K, Li X, Hu J, Tan M, Zhang M
Clin Cosmet Investig Dermatol. 2023; 16:443-451.
PMID: 36815200
PMC: 9939794.
DOI: 10.2147/CCID.S396997.
Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab.
Midtbo H, Kringeland E, Gerdts E, Ueland P, Meyer K, Linde A
Int J Immunopathol Pharmacol. 2022; 36:3946320221111131.
PMID: 35968808
PMC: 9379959.
DOI: 10.1177/03946320221111131.
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience.
Roses Gibert P, De la Torre Gomar F, Saenz Aguirre A, Gimeno Castillo J, Gonzalez Perez R
Psoriasis (Auckl). 2022; 12:177-185.
PMID: 35791415
PMC: 9250788.
DOI: 10.2147/PTT.S367060.
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease.
Gisondi P, Geat D, Maurelli M, Degli Esposti L, Bellinato F, Girolomoni G
Vaccines (Basel). 2022; 10(5).
PMID: 35632402
PMC: 9142895.
DOI: 10.3390/vaccines10050646.
The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.
Guillet C, Seeli C, Nina M, Maul L, Maul J
Int J Womens Dermatol. 2022; 8(2):e010.
PMID: 35619672
PMC: 9112394.
DOI: 10.1097/JW9.0000000000000010.
Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting.
Strober B, Patil D, McLean R, Moore-Clingenpeel M, Guo N, Levi E
Dermatol Ther (Heidelb). 2022; 12(6):1351-1365.
PMID: 35551619
PMC: 9100304.
DOI: 10.1007/s13555-022-00740-y.
Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis.
Li L, Jiang X, Fu L, Zhang L, Feng Y
Clin Exp Med. 2022; 23(3):701-715.
PMID: 35499793
DOI: 10.1007/s10238-022-00827-y.
Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas.
Augustin M, Landeck L, Diemert S, Asadullah K, Hammann U, Ertner K
Dermatol Ther (Heidelb). 2022; 12(5):1121-1131.
PMID: 35403945
PMC: 8995418.
DOI: 10.1007/s13555-022-00714-0.
